Gastrin I (human): Atomic Mechanisms in Gastric Acid Secretion Research

Executive Summary: Gastrin I (human) is a high-purity endogenous peptide that stimulates gastric acid secretion by acting as a potent CCK2 receptor agonist (APExBIO). It enables precise modeling of receptor-mediated signal transduction in both traditional cellular and advanced organoid systems (Saito et al., 2025). The peptide is insoluble in water and ethanol but soluble in DMSO at ≥21 mg/mL, and is supplied as a lyophilized powder with ≥98% purity (HPLC/MS). Gastrin I (human) is especially valuable for mechanistic and translational research in gastrointestinal physiology, disease modeling, and therapeutic evaluation (see internal review). Proper storage and handling protocols are required for optimal experimental reproducibility.

Biological Rationale

Gastrin I (human) is a peptide hormone produced by G-cells in the human stomach and proximal duodenum. Its primary physiological role is to regulate gastric acid secretion via parietal cell activation. Through CCK2 (cholecystokinin-B/gastrin) receptor binding, Gastrin I triggers intracellular cascades that ultimately stimulate H⁺/K⁺-ATPase (proton pump) activity, increasing gastric acid output (Saito et al., 2025). This pathway is crucial for digestion, nutrient absorption, and maintaining the gastric environment. Dysfunction in gastrin signaling is implicated in gastrointestinal disorders such as peptic ulcer disease, Zollinger-Ellison syndrome, and certain gastric cancers (review). Modern in vitro and organoid models leverage Gastrin I to dissect these mechanisms with species-specific fidelity, overcoming limitations of animal models and traditional cell lines.

Mechanism of Action of Gastrin I (human)

Gastrin I (human) acts by binding the CCK2 receptor (also known as the gastrin/CCK-B receptor), a G-protein-coupled receptor (GPCR) expressed on gastric parietal cells, ECL (enterochromaffin-like) cells, and some neurons. Upon ligand binding, the CCK2 receptor activates phospholipase C via G_q proteins, leading to increased intracellular IP₃ and Ca²⁺ mobilization. This cascade triggers exocytosis of histamine from ECL cells and directly stimulates parietal cells to secrete HCl via the H⁺/K⁺-ATPase pump (Saito et al., 2025). Gastrin I also modulates gene expression related to cell proliferation and differentiation in the gastric mucosa. The peptide's activity is highly specific for the human CCK2 receptor isoform, making it particularly suitable for translational and human-relevant research workflows.

Evidence & Benchmarks

• Gastrin I (human) exhibits ≥98% purity by HPLC and mass spectrometry under standard conditions (B5358 product QC, APExBIO).
• CCK2 receptor activation by Gastrin I (human) results in rapid Ca²⁺ mobilization within 5–10 minutes at 37°C in in vitro parietal cell assays (Saito et al., 2025).
• Solubility profile: insoluble in water and ethanol; soluble in DMSO at concentrations ≥21 mg/mL (manufacturer data, APExBIO).
• Enables reproducible stimulation of gastric acid secretion in human iPSC-derived organoid models, outperforming rodent analogs in fidelity (Saito et al., 2025).
• Storage at -20°C (desiccated) maintains stability for ≥12 months; solutions degrade rapidly and are not suitable for long-term storage (B5358 datasheet, APExBIO).

This article adds atomic detail and updated benchmarking to prior reviews, such as Gastrin I (human): Atomic Insights for Gastric Acid Secretion, by including organoid-specific protocols and rigorous purity/solubility metrics.

Applications, Limits & Misconceptions

Gastrin I (human) is widely used across several research domains:

• Modeling gastric acid secretion pathways in human-relevant systems, including hiPSC-derived intestinal organoids (Saito et al., 2025).
• Dissecting CCK2 receptor signaling and downstream gene regulation in gastrointestinal physiology studies (see review).
• Evaluating candidate therapeutics for GI disorders involving hypergastrinemia or acid dysregulation.
• Benchmarking proton pump activity and parietal cell responses in translational workflows.

Common Pitfalls or Misconceptions

• Gastrin I (human) does not activate CCK1 (A-type) receptors; use is restricted to CCK2 receptor-mediated pathways (Saito et al., 2025).
• Peptide is not suitable for long-term solution storage; rapid degradation can confound results if used after extended reconstitution.
• Species specificity: rodent models may not fully recapitulate human CCK2 receptor pharmacodynamics; cross-species extrapolation requires caution.
• Insolubility in aqueous buffers limits some experimental designs; strict adherence to DMSO protocols is required.
• Not intended for in vivo clinical or diagnostic use—research use only as per APExBIO guidelines.

Workflow Integration & Parameters

For optimal experimental outcomes, follow these parameters:

• Reconstitute Gastrin I (human) in DMSO at concentrations ≥21 mg/mL; avoid water or ethanol.
• Aliquot and store lyophilized product at -20°C under desiccated conditions.
• Use freshly prepared solutions; avoid repeated freeze-thaw cycles.
• Apply to cell culture or organoid systems at validated doses (typically 1–100 nM), adjusting for model sensitivity and endpoint readout.

The B5358 kit from APExBIO provides high-purity material and detailed protocols. For advanced modeling in hiPSC-derived organoids, see updated protocols in Saito et al., 2025. Compared to Gastrin I (human): Next-Generation Tool, this article details solubility and workflow boundaries for greater practical reproducibility.

Conclusion & Outlook

Gastrin I (human) is an essential reagent for dissecting gastric acid secretion, CCK2 receptor signaling, and translational GI research. Its atomic mechanism, human specificity, and validated purity/solubility profiles enable reproducible, high-fidelity modeling of gastrointestinal physiology. As organoid and hiPSC-derived systems gain traction, Gastrin I (human) will remain integral for pharmacokinetic, disease modeling, and therapeutic evaluation workflows (Saito et al., 2025). For further reading, contrast our atomic workflow focus with troubleshooting strategies detailed in Precision Tool for Gastric Acid Secretion.